FDA Won't Contraindicate Off-Label Corticosteroid Use
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency uses New England Journal of Medicine to explain why it disagreed with its advisory committee's recommendation to strengthen safety labeling on epidural administration.